610 related articles for article (PubMed ID: 26876240)
21. Is concomitant treatment with steroids and radiotherapy more favorable than sequential treatment in moderate-to-severe graves orbitopathy?
Limone PP; Bianco L; Mellano M; Garino F; Giannoccaro F; Rossi A; Airaldi C; Nassisi D; Gino E; Deandrea M; Oldani B; Ruo Redda MG
Radiol Med; 2021 Feb; 126(2):334-342. PubMed ID: 32705522
[TBL] [Abstract][Full Text] [Related]
22. The influence of previous orbital irradiation on the outcome of rehabilitative decompression surgery in graves orbitopathy.
Baldeschi L; MacAndie K; Koetsier E; Blank LE; Wiersinga WM
Am J Ophthalmol; 2008 Mar; 145(3):534-540. PubMed ID: 18191092
[TBL] [Abstract][Full Text] [Related]
23. Quantification of Global Ocular Motility Impairment in Graves' Orbitopathy by Measuring Eye Muscle Ductions.
Campi I; Currò N; Vannucchi G; Covelli D; Simonetta S; Fugazzola L; Dazzi D; Pignataro L; Guastella C; Lazzaroni E; Pirola G; Salvi M
Thyroid; 2021 Feb; 31(2):280-287. PubMed ID: 32940167
[No Abstract] [Full Text] [Related]
24. Improvement of the MRI and clinical features of Asian Graves' ophthalmopathy by radiation therapy with steroids.
Ma Z; Ozaki H; Ishikawa Y; Jingu K
Jpn J Radiol; 2019 Aug; 37(8):612-618. PubMed ID: 31201593
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic outcomes of high-dose intravenous steroids in the treatment of dysthyroid optic neuropathy.
Currò N; Covelli D; Vannucchi G; Campi I; Pirola G; Simonetta S; Dazzi D; Guastella C; Pignataro L; Beck-Peccoz P; Ratiglia R; Salvi M
Thyroid; 2014 May; 24(5):897-905. PubMed ID: 24417307
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of combined parenteral and oral steroid therapy in Graves' orbitopathy.
Nedeljkovic Beleslin B; Ciric J; Zarkovic M; Stojkovic M; Savic S; Knezevic M; Stankovic B; Trbojevic B
Hormones (Athens); 2014; 13(2):222-8. PubMed ID: 24776622
[TBL] [Abstract][Full Text] [Related]
27. Radiotherapy for the treatment of thyroid eye disease-a prospective comparison: Is orbital radiotherapy a suitable alternative to steroids?
Grassi P; Strianese D; Piscopo R; Pacelli R; Bonavolontà G
Ir J Med Sci; 2017 Aug; 186(3):647-652. PubMed ID: 28050807
[TBL] [Abstract][Full Text] [Related]
28. Effects of Orbital Decompression on Lamina Cribrosa Depth in Patients with Graves' Orbitopathy.
Seo Y; Shin WB; Bae HW; Yoon JS
Korean J Ophthalmol; 2019 Oct; 33(5):436-445. PubMed ID: 31612654
[TBL] [Abstract][Full Text] [Related]
29. The therapeutic outcome to intravenous steroid therapy for active Graves' orbitopathy is influenced by the time of response but not polymorphisms of the glucocorticoid receptor.
Vannucchi G; Covelli D; Campi I; Origo D; Currò N; Cirello V; Dazzi D; Beck-Peccoz P; Salvi M
Eur J Endocrinol; 2014 Jan; 170(1):55-61. PubMed ID: 24128430
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of orbital radiotherapy for graves' orbitopathy.
Tanda ML; Bartalena L
J Clin Endocrinol Metab; 2012 Nov; 97(11):3857-65. PubMed ID: 22962421
[TBL] [Abstract][Full Text] [Related]
31. Clinical and radiological characteristics of Graves' orbitopathy patients showing spontaneous decompression.
Kang EM; Yoon JS
J Craniomaxillofac Surg; 2015 Jan; 43(1):48-52. PubMed ID: 25457466
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy.
Bartalena L; Krassas GE; Wiersinga W; Marcocci C; Salvi M; Daumerie C; Bournaud C; Stahl M; Sassi L; Veronesi G; Azzolini C; Boboridis KG; Mourits MP; Soeters MR; Baldeschi L; Nardi M; Currò N; Boschi A; Bernard M; von Arx G;
J Clin Endocrinol Metab; 2012 Dec; 97(12):4454-63. PubMed ID: 23038682
[TBL] [Abstract][Full Text] [Related]
33. Meta-analysis of methylprednisolone pulse therapy for Graves' ophthalmopathy.
Gao G; Dai J; Qian Y; Ma F
Clin Exp Ophthalmol; 2014 Nov; 42(8):769-77. PubMed ID: 24617953
[TBL] [Abstract][Full Text] [Related]
34. Effect of systemic steroid therapy in Graves' orbitopathy on regulatory T cells and Th17/Treg ratio.
Siomkajło M; Mizera Ł; Szymczak D; Kolačkov K; Grzegrzółka J; Bolanowski M; Daroszewski J
J Endocrinol Invest; 2021 Nov; 44(11):2475-2484. PubMed ID: 33866536
[TBL] [Abstract][Full Text] [Related]
35. Optimization of the treatment of moderate to severe and active thyroid orbitopathy considering the recommendations of the European Group on Graves' Orbitopathy (EUGOGO) [Optymalizacja leczenia umiarkowanej do ciężkiej i aktywnej orbitopatii tarczycowej z uwzględnieniem zaleceń European Group on Graves' Orbitopathy (EUGOGO)].
Nowak M; Marek B; Kos-Kudła B; Siemińska L; Londzin-Olesik M; Głogowska-Szeląg J; Nowak W; Kajdaniuk D
Endokrynol Pol; 2022; 73(4):756-777. PubMed ID: 36059167
[TBL] [Abstract][Full Text] [Related]
36. Treatment of mild, moderate-to-severe and very severe Graves' orbitopathy.
Marcocci C; Marinò M
Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):325-37. PubMed ID: 22632369
[TBL] [Abstract][Full Text] [Related]
37. Quality of life assessment in patients with Graves' disease and progressive infiltrative ophthalmopathy during combined treatment with methylprednisolone and orbital radiotherapy.
Kulig G; Andrysiak-Mamos E; Sowińska-Przepiera E; Kulig J; Karakiewicz B; Brodowski J; Robaczyk M; Homa K; Letkiewicz M; Syrenicz A
Endokrynol Pol; 2009; 60(3):158-65. PubMed ID: 19569015
[TBL] [Abstract][Full Text] [Related]
38. Quantitative analysis of extraocular muscle volume and exophthalmos reduction after radiation therapy to treat Graves' ophthalmopathy: A pilot study.
Kim M; Chang JH; Lee NK
Eur J Ophthalmol; 2021 Mar; 31(2):340-345. PubMed ID: 31496266
[TBL] [Abstract][Full Text] [Related]
39. Preoperative clinical features of reactivated of Graves' orbitopathy after orbital decompression.
Woo YJ; Kim JW; Yoon JS
Eye (Lond); 2017 Apr; 31(4):643-649. PubMed ID: 28060361
[TBL] [Abstract][Full Text] [Related]
40. The role of intravenous methylprednisolone immunosuppression in the management of active thyroid eye disease.
Tambe K; Bhargava J; Tripathi A; Gregory M; Burns J; Sampath R
Orbit; 2010 Oct; 29(5):227-31. PubMed ID: 20812826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
